What is the market price of a box of Osimertinib/Tagressa in 2025?

Osimertinib/Tagressa (Osimertinib) is a targeted drug used to treat non-small cell lung cancer (NSCLC), especially for patients with EGFR mutation-positive patients. It is a third-generation EGFR tyrosine kinase inhibitor (TKI) that can effectively inhibit the growth and reproduction of tumor cells caused by EGFR mutations. Osimertinib has good bioavailability and tissue penetration ability, and can effectively combat drug-resistant mutations, especially the T790M mutation, making it of great clinical concern.

The launch of osimertinib in China has brought new hope to many patients with non-small cell lung cancer. Common dosage forms include 80 mg 30 tablets and 40 mg 30 tablets, with the market price per box ranging from RMB 4,000 to RMB 6,000. This price may cause a certain financial burden for patients, but it is worth mentioning that osimertinib has been included in the national medical insurance, which means that eligible patients can enjoy medical insurance reimbursement, thus reducing the pressure on treatment costs. The implementation of this policy has greatly improved the accessibility of drugs, allowing more patients to receive effective treatment.

In the international market, the price of the original drug of osimertinib is usually high, and the price in some regions may exceed US$10,000, which makes it financially unaffordable for many patients. In order to solve this problem, many generic drugs have also appeared in overseas markets. For example, although generic osimertinib from Laos, Bangladesh and other countries is a copycat, its pharmaceutical ingredients are basically the same as the original drug, its efficacy is similar, and its price is relatively affordable. Taking 80mg*30 tablets produced in Laos as an example, the price may be only more than 800 yuan (the specific price varies due to exchange rate fluctuations), which provides a more economical option for patients in need of treatment.

Reference materials:https://go.drugbank.com/drugs/DB09330